DBM market seen reaching $1.52 billion by 2030

The demineralized bone matrix market is projected to grow from $1.2 billion in 2026 to $1.52 billion by 2030, driven by more orthopedic and dental surgeries, new bioactive materials and wider use in minimally invasive procedures. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Demand for demineralized bone matrix, or DBM, is rising as hospitals and surgeons look for better bone-healing materials in orthopedic and dental care. - The market’s growth reflects more spinal fusion, joint reconstruction and fracture repair procedures. - The report’s forecast suggests DBM remains a key category in regenerative bone solutions over the next several years.

What happened: - The Business Research Company released a 2026 market outlook for the demineralized bone matrix market. - The market is projected to increase from $1.12 billion in 2025 to $1.2 billion in 2026, a 6.6% CAGR. - The market is expected to reach $1.52 billion by 2030, with a 6.3% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region through the forecast period.

The details: - DBM is an allograft made by removing the mineral content from human bone. - The process leaves an organic collagen matrix with growth factors and bone morphogenetic proteins, or BMPs. - DBM is used in orthopedic and dental surgeries as a scaffold that supports bone formation and regeneration. - The report links prior market growth to a shortage of allograft bone materials, reliance on traditional bone grafts, higher orthopedic and dental surgery volumes, greater awareness of bone-healing options and more standardized surgical protocols. - The forecast cites bioactive gels, collagen matrix technologies, more spinal fusion and joint reconstruction procedures, expansion of specialty clinics and ambulatory surgical centers, more regulatory clearances and minimally invasive surgery adoption. - The report flags growing use in orthopedic surgery, dental and craniomaxillofacial treatment, spinal fusion and long bone repair. - A free sample of the report is available as a sample report. - The full report is available as the full market report.

Between the lines: - The market outlook is being pushed by an aging population and more orthopedic disease, not just by product innovation. - An Institute for Health Metrics and Evaluation survey in August 2023 found that 15% of people age 30 and older in the U.S. had osteoarthritis in 2023. - The same survey projected the global number of people with osteoarthritis could approach 1 billion by 2050. - That burden increases the need for materials that can support surgical repair and recovery. - The regional split also points to a mature North American market and a faster-expanding Asia-Pacific opportunity.

What's next: - The report expects continued growth in injectable and thermosensitive DBM gels. - Collagen-based and bioactive bone regeneration materials are likely to gain more attention. - Specialized clinics and ambulatory surgical centers may become more important buyers as procedure volumes rise. - Regulatory clearances and minimally invasive techniques could further expand DBM adoption.

The bottom line: - DBM is moving from a niche grafting material toward broader use in bone repair, and the market outlook points to steady global expansion through 2030.